KRAS and colorectal carcinoma: Knockdown of UBQLN2 significantly reduced clonogenicity in three KRAS-Mutant CRC lines, validating our recent study where we found a synthetic lethal interaction between UBQLN2 and mutant KRAS in DLD1 cells [26].